Exodus Point Capital Management, LP Outlook Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.78 - $2.76 $252,571 - $391,627	-141,894 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.94 - $3.31 $98,041 - $345,229	104,299 Added 277.43%	141,894 $319,000
Q4 2020 Feb 16, 2021	BUY	$0.7 - $1.58 $26,316 - $59,400	37,595 New	37,595 $49,000
Q1 2020 May 15, 2020	SELL	$0.51 - $1.08 $5,610 - $11,880	-11,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.53 - $1.59 $5,830 - $17,490	11,000 New	11,000 $6,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $536M
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.